This site uses cookies to enhance your browsing experience. By continuing navigation, you agree to the use of cookies. For more information about our use of cookies, see our Privacy Policy.
Edwards Lifesciences acquires Endotronix
FDA approval of the Cordella PA Sensor
PROACTIVE-HF 6-month primary endpoint data released at THT 2024
500 Cordella PA sensor implants worldwide
1st implant in the PROACTIVE-HF pivotal trial
1st implant in the SIRONA 2 feasibility trial
First-in-human implant of the Cordella PA Sensor as part of the SIRONA trial
Harry Rowland, PhD and Anthony Nunez, MD found Endotronix to improve care for HF patients using PA sensing technology
We believe collaboration and trust drive our success. Our highly entrepreneurial work environment encourages responsibility, teamwork and a genuine sense of camaraderie.
Careers
